AGM-1470

夫马吉欣

Report date: 2023/12/08 11:53:33
NME

Base Information

Drug NameAGM-1470
Drug Alias NameAGM-1470TNP-470
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMethionine aminopeptidase 2 inhibitorsAngiogenesis inhibitors
TargetsMethionine aminopeptidase 2
Therapy Area/IndicationsPancreatic NeoplasmsNeoplasmsSarcoma, Kaposi +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaPending
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer CenterNational Institute Of Allergy And Infectious Diseases (Niaid)Changchun Tiancheng Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsNeoplasmsSarcoma, Kaposi +[4] 

Other Information

ATC CodeN/A
Related LinksN/A